Patient Safety Screening and Medical Evaluation Before considering any GLP-1 or phentermine therapyespecially in combinationproviders typically review cardiovascular history, blood pressure, heart rate, family history of stroke or MI, and baseline metabolic labs
Attenuated Nicotine Reward: Research suggests that GLP-1 therapy can reduce the reinforcing properties of nicotine, making smoking less appealing
Who might be better suited for Cagrilintide
Patients with uncontrolled tachyarrhythmias, recent acute coronary syndrome, or unstable heart conditions should exercise caution and require thorough cardiovascular assessment before starting treatment
It also minimizes fat buildup around muscles , allowing better muscle definition and vascularity
Clinical research, patient data, and real world experience provide us a full circle look at its promise, especially for menopausal women